Ruypeptide Biotechnology Co., Ltd.** is expanding its international presence by strengthening its biotechnology research capabilities, manufacturing capacity, and global customer support as demand for ...

Jubilant Biosys, an integrated drug discovery and development partner, convened the 2nd EDGE Innovation Forum in San Diego on ...

The United States's dominance in biotech innovation is crucial to our national interests and global security. In recent years, China has quickly become a powerhouse, bolstered by its biotech-friendly ...

This article is authored by Dhananjay Singh, managing director, Merck Life Science & head, Discovery Solutions, India.

China’s biotech sector is surging. For the first time, it now leads the world in clinical trials and new drug licensing. The U.S., once the undisputed leader in pharmaceutical innovation, risks losing ...

SAN FRANCISCO--(BUSINESS WIRE)--As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18 th year, the event continued to distinguish itself as a leading hub for early-stage biotechnology ...

Germany-headquartered science and technology giant Merck will continue to deepen its presence in China's healthcare sector, ...

Biopharmaceutical innovation has traditionally been difficult to capture through market exposures. This article explores how ...

The American Biotech Innovation Alliance (ABIA) today announced its launch, bringing together biotechnology leaders from across the United States around a shared objective: to define a national ...

New initiative under NSG Bio Tomorrow will support promising startups developing next-generation approaches in respiratory and neonatal care ...

India's NITI Aayog has unveiled a blueprint for a $691 billion bioeconomy by 2035, proposing a ₹50,000-crore growth fund, six ...

One offers global diversification and higher income; the other delivers focused biotech exposure with lower costs and ...